SignatureFD’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72 Hold
25
﹤0.01% 3452
2026
Q1
$49 Hold
25
﹤0.01% 3414
2025
Q4
$68 Hold
25
﹤0.01% 3332
2025
Q3
$106 Sell
25
-398
-94% -$1.75K ﹤0.01% 3321
2025
Q2
$2.11K Buy
423
+215
+103% +$934 ﹤0.01% 2854
2025
Q1
$917 Buy
208
+39
+23% +$183 ﹤0.01% 3057
2024
Q4
$786 Buy
169
+144
+576% +$792 ﹤0.01% 3071
2024
Q3
$174 Buy
+25
New +$196 ﹤0.01% 3170
2023
Q2
Sell
-157
Closed -$981 3287
2023
Q1
$981 Sell
157
-3
-2% -$17 ﹤0.01% 3000
2022
Q4
$746 Buy
160
+113
+240% +$557 ﹤0.01% 3030
2022
Q3
$0 Buy
+47
New +$296 ﹤0.01% 3182
2022
Q1
Sell
-15
Closed 3200
2021
Q4
$0 Sell
15
-35
-70% -$1.41K ﹤0.01% 3160
2021
Q3
$2K Buy
+50
New +$1.81K ﹤0.01% 2640
2021
Q2
Sell
-40
Closed -$2K 2983
2021
Q1
$2K Sell
40
-2,000
-98% -$89.9K ﹤0.01% 2469
2020
Q4
$82K Buy
2,040
+2,035
+40,700% +$93.5K ﹤0.01% 866
2020
Q3
$0 Buy
+5
New +$265 ﹤0.01% 2651

Other funds holding GDRX

SignatureFD's GDRX Position: Q2 2026 in Review

SignatureFD held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 25 shares worth $72. The position accounts for ﹤0.01% of the portfolio, ranked #3452.

SignatureFD first reported a position in GDRX in Q3 2020 and has held it in 16 quarters since. The position peaked at $82K in Q4 2020. 22 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • SignatureFD held 25 shares of GoodRx Holdings worth $72 as of Q2 2026.
  • SignatureFD left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3452 holding.
  • SignatureFD first reported a position in GoodRx Holdings in Q3 2020 and has held it in 16 quarters since.
  • SignatureFD's GoodRx Holdings position peaked at $82K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.